Evidence map›Paper›PMID 15956344›Full record

ArticleJournal of molecular endocrinology2005

Endocrinomic profile of neurointermediate lobe pituitary prohormone processing in PC1/3- and PC2-Null mice using SELDI-TOF mass spectrometry.

Atira Hardiman, Theodore C Friedman, William C Grunwald, Machi Furuta, Ziaorong Zhu, Donald F Steiner, David R Cool

Abstract read
In one paragraph

Article in Journal of molecular endocrinology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Atira HardimanDepartment of Pharmacology and Toxicology, School of Medicine, Wright State University, Dayton, Ohio 45435, USA.
Theodore C Friedman
William C Grunwald
Machi Furuta
Ziaorong Zhu
Donald F Steiner
David R Cool

Funding

TRANSGENIC COREP60DK020595 · NIDDK · UNIVERSITY OF CHICAGO · PI BELL, GRAEME I · 1985 to 2012
$25.5M
Pilot and Feasibility ProgramP30DK020595 · NIDDK · UNIVERSITY OF CHICAGO · PI RONALD N COHEN · 2013 to 2026
$20.9M
TRANSLATIONAL RESEARCH CORE: DIABETESU54RR014616 · NCRR · CHARLES R. DREW UNIVERSITY OF MED &SCI · PI CASTELLANOS, MANUEL · 1999 to 2009
$15.8M
STUDIES ON PANCREATIC HORMONESR01DK013914 · NIDDK · UNIVERSITY OF CHICAGO · PI STEINER, DONALD F · 1986 to 2011
$5.5M
Drew MIDARP (Infrastructure in Drug Abuse Research)R24DA017298 · NIDA · CHARLES R. DREW UNIVERSITY OF MED &SCI · PI FRIEDMAN, THEODORE C · 2004 to 2018
$5.0M
Vasopressin Cytotoxicity in Inherited Diabetes InsipidusR01DK058111 · NIDDK · WRIGHT STATE UNIVERSITY · PI COOL, DAVID R · 2001 to 2005
$1.2M
The Role of LRRK2 in the Pathogenesis of Parkinson's DiseaseR00NS058111 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WEST, ANDREW B · 2008 to 2010
$722k
The Role of LRRK2 in the Pathogenesis of Parkinson's DiseaseK99NS058111 · NINDS · JOHNS HOPKINS UNIVERSITY · PI WEST, ANDREW B · 2007 to 2007
$90k
STUDIES ON PANCREATIC HORMONESR37DK013914 · NIDDK · UNIVERSITY OF CHICAGO · PI STEINER, DONALD F · 1990 to 1997
–
NCRR NIH HHS U54 RR014616NCRR NIH HHS U54 RR14616-01NIDA NIH HHS R24 DA017298NIDDK NIH HHS DK13914NIDDK NIH HHS DK20595NIDDK NIH HHS P30 DK020595NIDDK NIH HHS P60 DK020595NIDDK NIH HHS R01 DK013914NIDDK NIH HHS R01 DK058111NIDDK NIH HHS R01DK/NS58111NINDS NIH HHS K99 NS058111NINDS NIH HHS R00 NS058111
6 · The paper itself

Abstract

Pro-vasopressin and pro-oxytocin are prohormones processed in the neurointermediate lobe pituitary to form the biologically active peptide hormones, arginine vasopressin (AVP) and oxytocin. Neurointermediate lobe pituitaries from normal (+/+), heterozygous (+/-), PC2-Null (-/-), PC1/3-Null and oxytocin-Null mice were analyzed by SELDI-TOF mass spectroscopy for the peptide hormone products, AVP, oxytocin and neurophysin I and II. Molecular ion species with masses characteristic of oxytocin, AVP, neurophysin I and II, i.e. 1009.41, 1084.5, 9677 and 9679 daltons respectively, were identified in all but the oxytocin-Null mice by comparison with synthetic standards or by C-terminal sequence analysis. Other ion species were found specifically in PC2-Null, heterozygote or normal mice. The results indicate that, in mice, both PC1/3 or PC2 enzyme activity are capable, but not required to correctly process pro-vasopressin or pro-oxytocin to their constituent active peptide hormones.

Indexed as

Amino Acid SequenceAnimalsArginine VasopressinHumansMass SpectrometryMiceMice, KnockoutMolecular Sequence DataNeurophysinsOxytocinPituitary GlandProprotein Convertase 1Proprotein Convertase 2Protein PrecursorsProteomeArginine VasopressinNeurophysinsOxytocinoxytocin, Gly-Lys-Arg-Proprotein Convertase 1Proprotein Convertase 2Protein PrecursorsProteome

Identifiers

PMID15956344
PMCPMC4422198

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.